CN101524435A - 一种治疗病毒性肝炎的纯天然药物 - Google Patents
一种治疗病毒性肝炎的纯天然药物 Download PDFInfo
- Publication number
- CN101524435A CN101524435A CN200910136005A CN200910136005A CN101524435A CN 101524435 A CN101524435 A CN 101524435A CN 200910136005 A CN200910136005 A CN 200910136005A CN 200910136005 A CN200910136005 A CN 200910136005A CN 101524435 A CN101524435 A CN 101524435A
- Authority
- CN
- China
- Prior art keywords
- viral hepatitis
- pure natural
- treating viral
- natural drug
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 21
- 201000001862 viral hepatitis Diseases 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 229940079593 drug Drugs 0.000 title abstract description 5
- 241001136306 Hydrophiidae Species 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 4
- 241000522620 Scorpio Species 0.000 claims description 4
- 239000009490 scorpio Substances 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241000195474 Sargassum Species 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 240000007284 Stenochlaena palustris Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000700605 Viruses Species 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010019755 Hepatitis chronic active Diseases 0.000 description 1
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940100691 oral capsule Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910136005A CN101524435A (zh) | 2009-04-23 | 2009-04-23 | 一种治疗病毒性肝炎的纯天然药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910136005A CN101524435A (zh) | 2009-04-23 | 2009-04-23 | 一种治疗病毒性肝炎的纯天然药物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101524435A true CN101524435A (zh) | 2009-09-09 |
Family
ID=41092610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910136005A Pending CN101524435A (zh) | 2009-04-23 | 2009-04-23 | 一种治疗病毒性肝炎的纯天然药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101524435A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861198A (zh) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | 一种治疗肝硬化腹水的纯中药制剂 |
CN105641168A (zh) * | 2016-02-19 | 2016-06-08 | 周华增 | 一种治疗乙、丙病毒性肝炎的药物及其制备方法 |
-
2009
- 2009-04-23 CN CN200910136005A patent/CN101524435A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102861198A (zh) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | 一种治疗肝硬化腹水的纯中药制剂 |
CN105641168A (zh) * | 2016-02-19 | 2016-06-08 | 周华增 | 一种治疗乙、丙病毒性肝炎的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102688303A (zh) | 一种养生护肝茶及其制备方法 | |
CN102423442B (zh) | 一种用于治疗脂肪肝的双组方药物及其制备方法 | |
CN103041285A (zh) | 一种用中药治疗脑中风后遗症的方法 | |
CN102488743B (zh) | 中药组合物、制备方法及中药制剂 | |
CN102210719A (zh) | 中药药砖的制作方法 | |
CN102784248A (zh) | 一种防治酒精性肝损伤的中药组合物 | |
CN104840871A (zh) | 一种治疗酒精性肝损害的中药 | |
CN102114172A (zh) | 一种治疗前列腺增生的中药 | |
CN102091268A (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
CN101524435A (zh) | 一种治疗病毒性肝炎的纯天然药物 | |
CN105250427A (zh) | 一种治疗心脏疾病的药物组合物 | |
CN101757206A (zh) | 用于治疗慢性结肠炎的中药制剂 | |
CN101085088A (zh) | 治疗前列腺增生的中药方剂 | |
CN102423441A (zh) | 一种用于治疗便秘的双组方药物及其制备方法 | |
CN102068529A (zh) | 一种治疗前列腺增生的中药 | |
CN1261130C (zh) | 一种祛癣药物 | |
CN100488495C (zh) | 一种治疗风湿、骨质增生和骨质疏松的中药制剂及其制备方法 | |
CN100998666B (zh) | 一种治疗寒凝血瘀型三叉神经痛的内服中药 | |
CN101095810B (zh) | 一种治疗脂溢性皮炎的汤剂药物及制备方法 | |
CN101002890A (zh) | 一种治疗肝火上炎型三叉神经痛的内服中药 | |
CN104258291A (zh) | 一种预防治疗酒精肝和脂肪肝的中草药保健口服液 | |
CN105641168A (zh) | 一种治疗乙、丙病毒性肝炎的药物及其制备方法 | |
CN103816347B (zh) | 一种生胃养生生物制剂 | |
CN101612233B (zh) | 一种消肿止痛的中药制剂 | |
CN101843726B (zh) | 一种治疗慢性肝炎的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHANGJIANG XIANBO SCIENCE + TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: MO YIXIAN Effective date: 20110131 Free format text: FORMER OWNER: REN ZHIJIE |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 524044 NO.91 (ZHANJIANG XIANBO TECHNOLOGY CO., LTD.), NORTH OF HAIBIN AVENUE, ZHANJIANG CITY, GUANGDONG PROVINCE TO: 524044 ROOM 806, NO.61, SOUTH OF HAIBIN AVENUE, DEVELOPMENT AREA, ZHANJIANG CITY, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110131 Address after: 806, room 61, 524044, Haibin Avenue, Zhanjiang Development Zone, Guangdong, China Applicant after: Zhanjiang Xianbo Technology Co., Ltd. Address before: 524044, No. 91, Haibin Avenue, Zhanjiang City, Guangdong province (Zhanjiang Yin Bo Technology Co., Ltd.) Applicant before: Mo Yixian Co-applicant before: Ren Zhijie |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20090909 |